Ligand Pharmaceuticals | LGND - PE Price to Earnings


Ligand Pharmaceuticals reported $60.65 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Amgen USD 25.31 15.82 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
Baxter International USD 17.1 4.46 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Gilead Sciences USD 15.63 0.08 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Intrexon 7.54 221.44 Dec/2021
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Ligand Pharmaceuticals USD 60.65 17.62 Sep/2025
Merck USD 13.92 5.08 Dec/2025
Pacira USD 29.24 6.15 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte USD 45.3 5.4 Dec/2025